Instrument Inactif

Communiqués MDxHealth SA Euronext Bruxelles

Actions

MDXH

BE0974461940

Recherche biotechnologique et médicale

Communiqués

03/04	MDxHealth : Annual Report for Fiscal Year Ending December 31, 2025 (Form 20-F)	PU
14/08/25	Interim report for the six months ended June 30, 2025: English	PU
03/06/25	MDxHealth : English (MDXH 1Q25)	PU
07/05/25	MDxHealth : Francais (3FR. 2024 combined annual report FR)	PU
07/05/25	MDxHealth : Francais (1FR. Comptes Annuels Statutaires non consolides)	PU
07/05/25	MDxHealth : English (5EN. MDxHealth SA IFRS Report conso financial statements 31 12 2024)	PU
07/05/25	MDxHealth : Francais (5FR. MDxHealth SA IFRS Rapport consolide 31 12 2024)	PU
11/12/24	MDxHealth : English (Q3 financials)	PU
26/11/24	MDxHealth to Participate in Piper Sandler Healthcare Conference	AQ
29/10/24	MDxHealth : Underwriting Agreement Form 6 K	PU
30/09/24	MDxHealth : SECURITIES PURCHASE AGREEMENT Form 6 K	PU
04/09/24	MDxHealth : Financial Reports	PU
21/08/24	MDxHealth Reports Q2 and Half Year 2024 Results	AQ
13/08/24	MDxHealth to Present Second Quarter and First Half 2024 Financial Results and Corporate Update on August 21	AQ
12/08/24	MDxHealth to Present Second Quarter and First Half 2024 Financial Results and Corporate Update on August 21	AQ
08/07/24	MDxHealth Reports Preliminary Q2 and Half Year 2024 Revenues and Raises 2024 Revenue Guidance	AQ
08/07/24	Mdxhealth Appoints Sanford J. Siegel, M.D. to Board of Directors	AQ
20/06/24	MDxHealth : REGISTRATION RIGHTS AGREEMENT Form 6 K	PU
05/06/24	MDxHealth : Extraordinary GENERAL MEETING Form 6 K	PU
16/05/24	MDxHealth : Financial Reports	PU
16/05/24	MDxHealth : Financial Reports	PU
15/05/24	Mdxhealth to Present at Upcoming Investor Conferences	AQ
06/05/24	MDxHealth : CEO PURCHASES SHARES OF MDXHEALTH - Form 6-K	PU
02/05/24	MDxHealth : Financial Reports	PU
01/05/24	MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed	AQ